N-Acetylcysteine (NAC) Treatment for tuberculosis

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 22 Aug 2025: Trial registered, NCT07136987

The trials

NCT07136987: A Trial of 2 Disease-Modifying Drugs (Metformin and N-acetylcysteine ) to Promote TB Lung Function Recovery

State
Not started
Phase
Phase 3
People
1,104 planned
Started
Jan 2026
Primary completion
Jan 2031
Arms
N-acetylcysteine (NAC) plus SOC
Results
None posted
  1. 22 Aug 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Diet or lifestyle.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.